The health claims apply to Cereboost when included at a 200 mg daily dose.
Health Canada has approved Cereboost, an American ginseng ingredient from Naturex (Avignon, France), for cognitive health claims as well as a natural product number (NPN) indicating Health Canada reviewed the ingredient for safety and efficacy.
Cereboost, when included at a 200 mg daily dose, can now tout the following health claims in the Canadian market: 1) helps support cognitive function, 2) helps support cognitive performance, and 3) helps support working memory.
“Our clients will gain multiple benefits from this recognition [by Health Canada],” said Maxence Duprez, sales director for Canada, in a Naturex press release. “They can register their finished products in a shorter period of time and drastically reduce the time-to-market of their launches.”
Read more about current and upcoming regulatory changes in Canada.
NPA files lawsuit against FDA for its decision on NMN
August 28th 2024The Natural Products Association (NPA; Washington, D.C.) has announced that they filed a lawsuit against the U.S. Food and Drug Administration (FDA) for its retroactive application of the Food, Drug, and Cosmetic Act (FD&C) against Nicotinamide Mononucleotide (NMN).
PLT Health Solution's Bosewellia serrata extract granted updated license by Health Canada
August 27th 2024The Natural and Non-Prescription Health Products Directorate (NNPHD) of Health Canada has granted PLT Health Solutions an updated license to market its AprèsFlex 5-Day Joint Support Ingredient in Canada.